The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists-Reference-Cited by-同舟云学术

The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists

Published:2022-08 Issue: Volume:182 Page:106320
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Bendotti Giulia,Montefusco Laura,Lunati Maria Elena,Usuelli Vera,Pastore Ida,Lazzaroni Elisa,Assi Emma,Seelam Andy Joe,El Essawy Basset,Jang Jun,Loretelli Cristian,D’Addio Francesca,Berra Cesare,Ben Nasr Moufida,Zuccotti GianVincenzo,Fiorina Paolo

Publisher

Elsevier BV

Subject

Pharmacology

Reference82 articles.

1. GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art;Nauck;Mol. Metab.,2021

2. Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis;Hogan;Diabetologia,2011

3. The cardiovascular biology of glucagon-like peptide-1;Drucker;Cell Metab.,2016

4. Anti-inflammatory effects of GLP-1-based therapies beyond glucose control;Lee;Mediat. Inflamm.,2016

5. Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function;Rowlands;Front. Endocrinol.,2018

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IDegLira improves time in range in a cohort of patients with type 2 diabetes: TiREX study;Acta Diabetologica;2024-09-05

2. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND);Frontiers in Pharmacology;2024-09-04

3. Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure;World Journal of Cardiology;2024-08-26

4. Retrospective Longitudinal Observational Study on the Long-Term Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetic Japanese Patients;Journal of Clinical Medicine;2024-08-21

5. Obesity and the gut microbiota: implications of neuroendocrine and immune signaling;The FEBS Journal;2024-08-19